. This study has shown that the quinolone antibiotic ciprofloxacin is concentrated in the bronchial mucosa.
Introduction
When the potential effectiveness of an antibiotic for respiratory infections is assessed sputum concentrations of the drug are often measured. Many antibiotics, however, do not penetrate well into sputum' and concentrations vary because of the diverse and unpredictable factors affecting bronchial secretions.2 Knowledge of the penetration of an antibiotic into bronchial mucosa and lung tissue may be more relevant. Obtaining lung tissue is obviously difficult and many studies have relied on measurement of antibiotic concentrations in samples of lung removed by thoracic surgeons-for example, for lung cancer. We have obtained samples of bronchial mucosa during fibreoptic bronchoscopy from patients pretreated with amoxycillin or the quinolone antibiotic ciprofloxacin and measured mucosal concentrations of the two drugs. In our experience bronchial biopsy samples consist mainly of mucosa, although a very small amount of submucosal tissue may also be present. We included a quinolone antimicrobial because recent work has shown that the drug is concentrated in the mucosa of the gastrointestinal (R Wise, unpublished observations) and genitourinary that the same is true for the respiratory mucosa. The results obtained with ciprofloxacin have been compared with those obtained with amoxycillin.
Methods
Patients who were undergoing diagnostic fibreoptic bronchoscopy were asked if they would agree to take an antibiotic (amoxycillin or ciprofloxacin) for four days before bronchoscopy and to have mucosal biopsies as well as the routine diagnostic biopsy. Patients gave written informed consent and the protocol was approved by the local ethical committee. The patients were not taking any other drugs known to influence antibiotic transport from the blood into bronchial tissue.
Study I Nine men (mean age 62 (SD 8 3) years) took oral amoxycillin 500 mg thrice daily for four days before bronchoscopy. Excluded from the study were those known to be allergic to f lactam antibiotics and those with severe cardiac, renal, or hepatic impairment. The time of the last dose was noted.
Study 2 Oral ciprofloxacin was given to 29 patients, of whom 21 were male (mean age 66 (SD 12-4) years).
Excluded from this study were those known to have a sensitivity to quinolones; those with severe cardiac, renal, or hepatic impairment or having concomitant theophylline treatment (as quinolones reduce the hepatic clearance of theophylline); pregnant or lactat-716 ing women; and patients with a history of epilepsy. The patients took 500 mg oral ciprofloxacin twice daily for four days before bronchoscopy, the last dose being taken on the morning of bronchoscopy. The time of the last dose was recorded. Study 3 Ten patients (five male: mean age 60 (SD 1 1) years) received an intravenous infusion of 200 mg ciprofloxacillin in 100 ml over 30 minutes on the day of the bronchoscopy.
All subjects in studies 1 and 3 and 19 subjects in study 2 were given a standard premedication of 10 mg morphine and 0-6 mg atropine one hour before bronchoscopy. The last 10 subjects in study 2 were given no premedication but instead had 5 mg intravenous midazolam at the beginning of the bronchoscopy procedure. All subjects in all three studies were given 4 ml 4% lignocaine by nebuliser 20 minutes before the procedure. Topical lignocaine was also given during bronchoscopy.
In addition to the samples taken for diagnostic purposes, bronchial biopsy samples were taken from both lungs via the fibreoptic bronchoscope for estimation of antibiotic concentrations. Three biopsy samples were taken from the subcarina between the right upper lobe and the bronchus intermedius, and three from the subcarina between the left upper and lower lobes. Samples were not used if they appeared to be abnormal macroscopically. Samples from the two lungs ofeach patient were subsequently processed and analysed separately. Venous blood was taken at the same time for assay of the serum concentration of the antibiotic and the time since the last dose of antibiotic was noted.
Biopsy samples were taken immediately to the laboratory and placed in a humidity chamber to prevent loss of moisture. Bloodstained samples were discarded. After the tissue had been weighed in a preweighed glass tube 200 p1 of chilled phosphate buffer (pH 7-0) was added. The (table) . This was higher than the mean percentage penetration of amoxycillin (75) (p < 0001), and the same was true when each lung was analysed separately (for left lung p < 0 001 and for right lung p < 0-01). The correlation between the drug concentrations in the biopsy sample and in serum was 0-68 (p < 0-01).
In study 3 samples were taken 0-33-2 hours after the end of the half hour infusion of ciprofloxacin 
)floxacin from serum to bronchial mucosa was apparent lack of correlation of sputum and serum (table). concentrations found by some workers' may be partly due to this effect of pooling. Antibiotics may be ussion unstable in bronchial secretions8 owing to change in temperature, pH, or protein content. These factors bronchial mucosa is probably the main site of may explain why lung tissue concentrations of e bacterial infection and inflammation in patients antibiotic show a much better correlation than sputum chronic bronchitis and bronchiectasis5 and one of concentrations.9 For similar reasons bronchial secresites affected in bronchopneumonia. Hence tions obtained at bronchoscopy will be diluted by the microbials that reach a concentration in the lignocaine used as the local anaesthetic or affected by chial mucosa higher than that required to inhibit the atropine commonly used as premedication and the ding pathogens might be assumed to be more pooling of respiratory secretions. tive in treatment than those with lower concenBronchial tissue concentration can be estimated by ons. This study has measured concentrations in accepting that a gradient exists from blood through chial mucosa samples from patients and related bronchial tissue to sputum. This would occur if the i to serum concentrations. The absolute drug only process were passive diffusion. The rate of ,entrations in bronchial mucosa and their relation penetration of antibiotics from blood to bronchial erum concentrations expressed as percentage secretions is, however, known to vary considerably tration may be more relevant than sputum con-from one drug to another even within the same group rations. Measurements of antibiotic concentra-of antibiotics-for example, amoxycillin appears to s in sputum are difficult to interpret because penetrate into bronchial secretions better than )us factors may affect them. Sputum is often ampicillin.' Physicochemical properties of antibiotics Led with saliva, in which the concentration of appear to be important in determining their penetrabiotic is usually lower than that in the sputum.67 tion into bronchial tissue and lung secretions. Lipoicular problems may arise when sputum concen-philic antibiotics are known to accumulate in lung ons are compared with serum concentrations at a tissue to a greater extent than lipid insoluble drugs icular time after a dose of antibiotic. Respiratory such as penicillins and cephalosporins.'°Protein bind--tions will pool in the lung and lead to an ing of antibiotics is probably important also, highly aging of sputum antibiotic concentrations,2 so protein bound antibiotics passing the "blood-bronthe peak sputum concentration will not be chus" barrier with difficulty. In the presence of sured and cannot be related to the minimum infection and bronchial inflammation some antibiotics bitory concentration of an organism. Honeybourne, Andrews, Ashby, Lodwick, Wise to be higher than serum concentrations. 20 The concentration of ciprofloxacin that we have found in bronchial mucosa has also been found in the mucosa of the gastrointestinal tract (penetration 240%) and in the fallopian tubes (penetration 350%). The mechanisms concerned in the concentration of quinolones in the mucosa and the clinical relevance merit further research. 
